SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2

MLA

Shaik, Shavali, et al. “SCFβ-TRCP Suppresses Angiogenesis and Thyroid Cancer Cell Migration by Promoting Ubiquitination and Destruction of VEGF Receptor 2.” The Journal of Experimental Medicine, vol. 209, no. 7, July 2012, pp. 1289–307. EBSCOhost, https://doi.org/10.1084/jem.20112446.

APA

Shaik, S., Nucera, C., Inuzuka, H., Gao, D., Garnaas, M., Frechette, G., Harris, L., Wan, L., Fukushima, H., Husain, A., Nose, V., Fadda, G., Sadow, P. M., Goessling, W., North, T., Lawler, J., & Wei, W. (2012). SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. The Journal of Experimental Medicine, 209(7), 1289–1307. https://doi.org/10.1084/jem.20112446

Chicago

Shaik, Shavali, Carmelo Nucera, Hiroyuki Inuzuka, Daming Gao, Maija Garnaas, Gregory Frechette, Lauren Harris, et al. 2012. “SCFβ-TRCP Suppresses Angiogenesis and Thyroid Cancer Cell Migration by Promoting Ubiquitination and Destruction of VEGF Receptor 2.” The Journal of Experimental Medicine 209 (7): 1289–1307. doi:10.1084/jem.20112446.